{"id":39320,"date":"2026-08-06T09:12:00","date_gmt":"2026-08-06T13:12:00","guid":{"rendered":"https:\/\/www.drugpatentwatch.com\/blog\/exelixis-inc-v-handa-pharmaceuticals-inc\/"},"modified":"2026-07-08T00:14:11","modified_gmt":"2026-07-08T04:14:11","slug":"exelixis-inc-v-handa-pharmaceuticals-inc","status":"publish","type":"post","link":"https:\/\/www.drugpatentwatch.com\/blog\/exelixis-inc-v-handa-pharmaceuticals-inc\/","title":{"rendered":"Exelixis, Inc. v. Handa Pharmaceuticals, Inc."},"content":{"rendered":"<h2><strong>Exelixis v. Handa Pharmaceuticals (1:26-cv-00813): Litigation Summary, Claims, Timeline, and Likely Case Posture<\/strong><\/h2>\n<p>Exelixis, Inc. v. Handa Pharmaceuticals, Inc., case number <strong>1:26-cv-00813<\/strong>, is pending in federal court. The publicly available record provided here is insufficient to extract the legally operative details needed for a reliable litigation summary and analysis (asserted patents, claim construction, parties\u2019 positions, procedural milestones, and outcomes). No actionable patent or motion-to-dismiss\/Markman\/settlement record can be stated without risking fabrication.<\/p>\n<h2><strong>What patents are asserted in Exelixis v. Handa Pharmaceuticals (1:26-cv-00813)?<\/strong><\/h2>\n<p><strong>Answer:<\/strong> Not provided in the available material.<\/p>\n<h3><strong>Which Orange Book patents or listed drug-product patents are in-scope<\/strong><\/h3>\n<p><strong>Answer:<\/strong> Not provided in the available material.<\/p>\n<h3><strong>How many patents are asserted and what patent types<\/strong><\/h3>\n<p><strong>Answer:<\/strong> Not provided in the available material.  <\/p>\n<ul>\n<li>Method-of-use vs. composition-of-matter vs. formulation vs. manufacturing patents: not available.<\/li>\n<\/ul>\n<h2><strong>What is the procedural posture of 1:26-cv-00813?<\/strong><\/h2>\n<p><strong>Answer:<\/strong> Not provided in the available material.<\/p>\n<h3><strong>What filings exist (complaint, answer, amended\u2026<\/strong><\/h3>","protected":false},"excerpt":{"rendered":"<p>Exelixis v. Handa Pharmaceuticals (1:26-cv-00813): Litigation Summary, Claims, Timeline, and Likely Case Posture Exelixis, Inc. v. Handa Pharmaceuticals, Inc., case [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":34556,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"","_lmt_disable":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[10],"tags":[],"class_list":["post-39320","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/39320","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/comments?post=39320"}],"version-history":[{"count":1,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/39320\/revisions"}],"predecessor-version":[{"id":39400,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/posts\/39320\/revisions\/39400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media\/34556"}],"wp:attachment":[{"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/media?parent=39320"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/categories?post=39320"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.drugpatentwatch.com\/blog\/wp-json\/wp\/v2\/tags?post=39320"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}